The Multiple Sclerosis Association of America (MSAA), a national nonprofit organization and leading resource for the MS community, and Antidote Technologies, a digital health company, have announced a partnership to increase awareness of MS clinical trials and enable people to easily access this important information. The Antidote Match clinical trial search tool will now be available on MSAA’s website, allowing visitors to find trials that are right for them or their loved ones in minutes, just by answering a few questions.
Read News ArticleCategory: Latest News
New Chairman Elected to the Multiple Sclerosis Association of America’s Board of Directors
The Multiple Sclerosis Associa …
Read News ArticleOcrevus™ (Ocrelizumab) Phase III Trial Results Published
The results from three Phase I …
Read News ArticleFDA Extends Review of Ocrevus™ (ocrelizumab)
On December 20, 2016, Genentec …
Read News ArticleHighlights from the 2016 ECTRIMS Annual Meeting
More than 9,000 clinicians and …
Read News ArticleMake Your Voice Heard on MS Treatment
The Institute for Clinical and …
Read News ArticleExperimental SPMS Medication Shows Positive Results
A Phase III study with siponim …
Read News ArticleThe Multiple Sclerosis Association of America Launches Online Support Community for Individuals Affected by MS
The Multiple Sclerosis Associa …
Read News ArticleHighlights from the AAN and CMSC Annual Meetings
Two vital conferences providin …
Read News ArticleMy MS Manager Named One of the Best MS Apps of 2016
My MS Manager™, MSAA’s free mo …
Read News Article